Short Term Outcome After Meniscectomy

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2013 by University Hospital, Ghent
Sponsor:
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT01158677
First received: July 7, 2010
Last updated: February 1, 2013
Last verified: February 2013
  Purpose

Short term outcome after meniscectomy: a meniscectomy is a very frequent performed orthopedically procedure. The short term outcome is favourable, but some patients keep having residual lesions after surgery.

This prospective study examens the clinical outcome after meniscectomy using questionnaires (KOOS, VAS, SF-36, Tegner) (before the surgery, 3, 6 & 12 months postoperative.) The investigators will also record the further treatment options for the people at risk.


Condition Intervention
Meniscectomy
Procedure: Meniscectomy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Short Term Outcome After Meniscectomy

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • The clinical outcome (residual lesions) after a meniscectomy [ Time Frame: 12 months post-operative ] [ Designated as safety issue: No ]
    KOOS-scale, Vas-scale, Tegner questionnaire, SF-36 questionnaire


Estimated Enrollment: 150
Study Start Date: July 2010
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Meniscectomy
    patients undergoing meniscectomy will be asked to complete the KOOS-scale,Vas-scale, Tegner questionnaire, SF-36 questionnaire pre-operatively and at 3, 6 and 12 months post-operatively
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

all the meniscectomy patients (male & female, all ages)

Criteria

Inclusion criteria:

  • all the meniscectomy patients (male & female, all ages)

Exclusion Criteria:None

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01158677

Contacts
Contact: Peter Verdonk, MD peter.verdonk@uzgent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium
Principal Investigator: Peter Verdonk, MD         
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Peter Verdonk, MD University Hospital Ghent, Belgium
  More Information

Additional Information:
No publications provided

Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT01158677     History of Changes
Other Study ID Numbers: 2010/117
Study First Received: July 7, 2010
Last Updated: February 1, 2013
Health Authority: Belgium: Ethics Committee

Keywords provided by University Hospital, Ghent:
meniscectomy

ClinicalTrials.gov processed this record on August 18, 2014